Eagle Wealth Advisors LLC

Position in ABBV — AbbVie Inc.

CIK 2107271 WESTPORT, CT

Position in ABBV

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$330,906

+$77,966 QoQ

Shares Held

1,315

+13.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#3,541

of 4,153 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Eagle Wealth Advisors LLC holds $3,436,635 across 6 Drug Manufacturers - General names. ABBV ranks #5 (9.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,097	$1,315,774
2	AMGN	Amgen Inc	1,673	$605,826
3	JNJ	Johnson & Johnson	1,872	$475,431
4	GILD	Gilead Sciences, Inc.	3,619	$457,224
5	ABBV	AbbVie Inc. This page	1,315	$330,906
6	MRK	Merck & Co., Inc.	1,957	$251,474

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$330,906	1,315	+13.1%	Shares	Sole	2026-07-13
2026-03-31	$252,940	1,163	+1.0%	Shares	Sole	2026-04-23
2025-12-31	$262,991	1,151	—	Shares	Sole	2026-01-29
No filing history on record for this holder in this stock.